| Name | 4-[(3-methoxyphenyl)methyl]piperidine |
|---|---|
| Synonyms |
4-(3-Methoxybenzyl)piperidine
Piperidine, 4-[(3-methoxyphenyl)methyl]- 3-methoxybenzyl-4-piperidine 4-(3-Methoxy-benzyl)-piperidine |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 322.7±22.0 °C at 760 mmHg |
| Molecular Formula | C13H19NO |
| Molecular Weight | 205.296 |
| Flash Point | 132.1±11.8 °C |
| Exact Mass | 205.146667 |
| PSA | 21.26000 |
| LogP | 2.84 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.520 |
| HS Code | 2933399090 |
|---|
|
~86%
150019-61-7 |
| Literature: Bristol-Myers Squibb Co. Patent: US5530012 A1, 1996 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |